India · Delayed Price · Currency is INR Dr. Reddy's Laboratories Statistics
Total Valuation
BOM:500124 has a market cap or net worth of INR 955.93 billion. The enterprise value is 949.76 billion.
| Market Cap | 955.93B |
| Enterprise Value | 949.76B |
Important Dates
The last earnings date was Wednesday, July 22, 2026.
| Earnings Date | Jul 22, 2026 |
| Ex-Dividend Date | Jul 10, 2026 |
Share Statistics
BOM:500124 has 832.98 million shares outstanding. The number of shares has decreased by -0.05% in one year.
| Current Share Class | 832.98M |
| Shares Outstanding | 832.98M |
| Shares Change (YoY) | -0.05% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 26.73% |
| Owned by Institutions (%) | 65.25% |
| Float | 599.97M |
Valuation Ratios
The trailing PE ratio is 28.89 and the forward PE ratio is 25.35. BOM:500124's PEG ratio is 4.74.
| PE Ratio | 28.89 |
| Forward PE | 25.35 |
| PS Ratio | 2.89 |
| PB Ratio | 2.47 |
| P/TBV Ratio | 3.58 |
| P/FCF Ratio | 44.86 |
| P/OCF Ratio | 23.20 |
| PEG Ratio | 4.74 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.81, with an EV/FCF ratio of 44.57.
| EV / Earnings | 28.69 |
| EV / Sales | 2.87 |
| EV / EBITDA | 16.81 |
| EV / EBIT | 26.90 |
| EV / FCF | 44.57 |
Financial Position
The company has a current ratio of 1.90, with a Debt / Equity ratio of 0.19.
| Current Ratio | 1.90 |
| Quick Ratio | 1.16 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | 1.28 |
| Debt / FCF | 3.38 |
| Interest Coverage | 8.45 |
Financial Efficiency
Return on equity (ROE) is 8.84% and return on invested capital (ROIC) is 7.46%.
| Return on Equity (ROE) | 8.84% |
| Return on Assets (ROA) | 4.01% |
| Return on Invested Capital (ROIC) | 7.46% |
| Return on Capital Employed (ROCE) | 8.41% |
| Weighted Average Cost of Capital (WACC) | 5.51% |
| Revenue Per Employee | 12.03M |
| Profits Per Employee | 1.20M |
| Employee Count | 27,527 |
| Asset Turnover | 0.60 |
| Inventory Turnover | 2.11 |
Taxes
In the past 12 months, BOM:500124 has paid 8.58 billion in taxes.
| Income Tax | 8.58B |
| Effective Tax Rate | 20.77% |
Stock Price Statistics
The stock price has decreased by -11.15% in the last 52 weeks. The beta is 0.24, so BOM:500124's price volatility has been lower than the market average.
| Beta (5Y) | 0.24 |
| 52-Week Price Change | -11.15% |
| 50-Day Moving Average | 1,269.18 |
| 200-Day Moving Average | 1,261.26 |
| Relative Strength Index (RSI) | 28.35 |
| Average Volume (20 Days) | 137,484 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:500124 had revenue of INR 331.19 billion and earned 33.11 billion in profits. Earnings per share was 39.72.
| Revenue | 331.19B |
| Gross Profit | 166.18B |
| Operating Income | 35.16B |
| Pretax Income | 41.30B |
| Net Income | 33.11B |
| EBITDA | 54.67B |
| EBIT | 35.16B |
| Earnings Per Share (EPS) | 39.72 |
Balance Sheet
The company has 81.43 billion in cash and 71.95 billion in debt, with a net cash position of 9.48 billion or 11.37 per share.
| Cash & Cash Equivalents | 81.43B |
| Total Debt | 71.95B |
| Net Cash | 9.48B |
| Net Cash Per Share | 11.37 |
| Equity (Book Value) | 386.74B |
| Book Value Per Share | 460.31 |
| Working Capital | 141.99B |
Cash Flow
In the last 12 months, operating cash flow was 41.20 billion and capital expenditures -19.89 billion, giving a free cash flow of 21.31 billion.
| Operating Cash Flow | 41.20B |
| Capital Expenditures | -19.89B |
| Depreciation & Amortization | 19.51B |
| Net Borrowing | 13.43B |
| Free Cash Flow | 21.31B |
| FCF Per Share | 25.58 |
Margins
Gross margin is 50.18%, with operating and profit margins of 10.62% and 10.00%.
| Gross Margin | 50.18% |
| Operating Margin | 10.62% |
| Pretax Margin | 12.47% |
| Profit Margin | 10.00% |
| EBITDA Margin | 16.51% |
| EBIT Margin | 10.62% |
| FCF Margin | 6.43% |
Dividends & Yields
This stock pays an annual dividend of 8.00, which amounts to a dividend yield of 0.70%.
| Dividend Per Share | 8.00 |
| Dividend Yield | 0.70% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 20.11% |
| Buyback Yield | 0.05% |
| Shareholder Yield | 0.75% |
| Earnings Yield | 3.46% |
| FCF Yield | 2.23% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for BOM:500124 is 1,262.63, which is 10.02% higher than the current price. The consensus rating is "Hold".
| Price Target | 1,262.63 |
| Price Target Difference | 10.02% |
| Analyst Consensus | Hold |
| Analyst Count | 40 |
| Revenue Growth Forecast (3Y) | 8.81% |
| EPS Growth Forecast (3Y) | 7.88% |
Stock Splits
The last stock split was on October 28, 2024. It was a forward split with a ratio of 5.
| Last Split Date | Oct 28, 2024 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
BOM:500124 has an Altman Z-Score of 5.29 and a Piotroski F-Score of 5.
| Altman Z-Score | 5.29 |
| Piotroski F-Score | 5 |